| 臺大學術典藏 |
2022-04-22T06:59:11Z |
Efficacy of breast cancer screening by age. New results swedish two-county trial
|
Tabar L.; Fagerberg G.; Chen, Tony Hsiu Hsi; Duffy S.W.; Smart C.R.; Gad A.; Smith R.A. |
| 臺大學術典藏 |
2022-04-21T06:51:58Z |
Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase
|
Duffy S.W.; Chen, Tony Hsiu Hsi; Tabar L.; Day N.E. |
| 臺大學術典藏 |
2022-04-21T06:51:57Z |
Screening for breast cancer in women aged under 50: Mode of detection, incidence, fatality, and histology
|
Tabar L.; Fagerberg G.; Chen, Tony Hsiu Hsi; Duffy S.W.; Gad A. |
| 臺大學術典藏 |
2022-04-21T06:51:57Z |
A Markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening
|
Chen, Tony Hsiu Hsi; Duffy S.W.; Tabar L. |
| 臺大學術典藏 |
2022-04-21T06:51:57Z |
Sojourn time, sensitivity and positiva predictive value of mammography screening for breast cancer in women aged 40-49
|
Duffy S.W.; Chen, Tony Hsiu Hsi; Tabar L.; Fagerberg G.; Paci E. |
| 臺大學術典藏 |
2022-04-21T06:51:57Z |
Population breast-cancer screening
|
Paci E.; Alexander F.E.; Anderson T.J.; Hakama M.; Thornton H.; Day N.E.; Tabar L.; Duffy S.W.; Chen, Tony Hsiu Hsi |
| 臺大學術典藏 |
2022-04-21T06:51:56Z |
A mover-stayer mixture of Markov chain models for the assessment of dedifferentiation and tumour progression in breast cancer
|
Chen, Tony Hsiu Hsi; Duffy S.W.; Tabar L. |
| 臺大學術典藏 |
2022-04-21T06:51:56Z |
Evaluation by Markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in Sweden
|
Chen, Tony Hsiu Hsi; Thurfjell E.; Duffy S.W.; Tabar L. |
| 臺大學術典藏 |
2022-04-21T06:51:56Z |
Tumour development, histology and grade of breast cancers: Prognosis and progression
|
Tabar L.; Fagerberg G.; Chen, Tony Hsiu Hsi; Duffy S.W.; Gad A. |
| 臺大學術典藏 |
2022-04-21T06:51:55Z |
Update of the Swedish two-county trial of breast cancer screening: Histologic grade-specific and age-specific results
|
Tabar L.; Vitak B.; Chen, Tony Hsiu Hsi; Prevost T.C.; Duffy S.W. |
| 臺大學術典藏 |
2022-04-21T06:51:54Z |
Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening
|
Tabar L.; Chen, Tony Hsiu Hsi; Duffy S.W.; Krusemo U.B. |
| 臺大學術典藏 |
2022-04-21T06:51:54Z |
The natural history of breast carcinoma: What have we learned from screening?
|
Tabár L.; Duffy S.W.; Vitak B.; Chen, Tony Hsiu Hsi; Prevost T.C. |
| 臺大學術典藏 |
2022-04-21T06:51:53Z |
Estimation of sojourn time in chronic disease screening without data on interval cases
|
Chen, Tony Hsiu Hsi; Kuo H.S.; Yen M.F.; Lai M.S.; Tabar L.; Duffy S.W. |
| 臺大學術典藏 |
2022-04-21T06:51:53Z |
The Swedish two-county trial twenty years later: Updated mortality results and new insights from long-term follow-up
|
Tabár L.; Vitak B.; Chen, Tony Hsiu Hsi; Duffy S.W.; Yen M.-F.; Chiang C.-F.; Krusemo U.B.; Tot T.; Smith R.A. |
| 臺大學術典藏 |
2022-04-21T06:51:52Z |
Mammographic screening in women with a family history of breast cancer: Some results from the Swedish two-county trial
|
Nixon R.M.; Pharoah P.; Tabar L.; Krusemo U.B.; Duffy S.W.; Prevost T.C.; Chen, Tony Hsiu Hsi |
| 臺大學術典藏 |
2022-04-21T06:51:52Z |
A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: A prospective study
|
Tabár L.; Chen, Tony Hsiu Hsi; Duffy S.W.; Yen M.F.; Chiang C.F.; Dean P.B.; Smith R.A. |
| 臺大學術典藏 |
2022-04-21T06:51:51Z |
Estimating the benefits of adjuvant systemic therapy for women with early breast cancer
|
Grogan M.; Tabar L.; Chua B.; Chen, Tony Hsiu Hsi; Boyages J. |
| 臺大學術典藏 |
2022-04-21T06:51:50Z |
Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes
|
Duffy S.W.; Cuzick J.; Tabar L.; Vitak B.; Chen, Tony Hsiu Hsi; Yen M.-F.; Smith R.A. |
| 臺大學術典藏 |
2022-04-21T06:51:49Z |
The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish Counties: A collaborative evaluation
|
Duffy S.W.; Tabár L.; Chen, Tony Hsiu Hsi; Holmqvist M.; Yen M.-F.; Abdsalah S.; Epstein B.; Frodis E.; Ljungberg E.; Hedborg-Melander C.; Sundbom A.; Tholin M.; Wiege M.; Åkerlund A.; Wu H.-M.; Tung T.-S.; Chiu Y.-H.; Chiu C.-P.; Huang C.-C.; Smith R.A.; Rosén M.; Stenbeck M.; Holmberg L. |
| 臺大學術典藏 |
2022-04-21T06:51:48Z |
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease
|
Duffy S.W.; Tabar L.; Vitak B.; Day N.E.; Smith R.A.; Chen, Tony Hsiu Hsi; Yen M.F.A. |
| 臺大學術典藏 |
2022-04-21T06:51:48Z |
All-cause mortality among breast cancer patients in a screening trial: Support for breast cancer mortality as an end point
|
Tabar L.; Duffy S.W.; Yen M.-F.; Warwick J.; Vitak B.; Chen, Tony Hsiu Hsi; Smith R.A. |
| 臺大學術典藏 |
2022-04-21T06:51:48Z |
Mammographic screening: A key factor in the control of breast cancer
|
Tabár L.; Smith R.A.; Vitak B.; Yen M.-F.; Chen, Tony Hsiu Hsi; Warwick J.; Myles J.P.; Duffy S.W. |
| 臺大學術典藏 |
2022-04-21T06:51:46Z |
Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening
|
Tabar L.; Yen M.-F.; Vitak B.; Tony Chen, Tony Hsiu Hsi; Smith R.A.; Duffy S.W. |
| 臺大學術典藏 |
2022-04-21T06:51:45Z |
The Swedish two-county trial of mammographic screening: Cluster randomisation and end point evaluation
|
Duffy S.W.; Tabar L.; Vitak B.; Yen M.F.; Warwick J.; Smith R.A.; Chen, Tony Hsiu Hsi |
| 臺大學術典藏 |
2022-04-21T06:51:41Z |
Number needed to screen: Lives saved over 20 years of follow-up in mammographic screening
|
Tabar L.; Vitak B.; Yen M.F.A.; Chen, Tony Hsiu Hsi; Smith R.A.; Duffy S.W. |
